Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 3 1Phase 2 1

Status

Unknown 3Withdrawn 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 35Genitourinary 11Breast 11Classical hematology 9Thoracic 8Plasma cell 8Myeloid 7Gynecologic 6Tumor-Agnostic 4Head & Neck 3Dermatologic 3Sarcoma 2CNS 2Other solid neoplasm 1Other neoplasm 1Other hematologic neoplasm 1Other 1Lymphoid 1

Conditions

Neoplasms 3Carcinoma, Squamous Cell 1

Interventions

Surveys and Questionnaires 70Blood Specimen Collection 48Radiotherapy 39Magnetic Resonance Spectroscopy 35pembrolizumab 31Gemcitabine 30Bevacizumab 30Nivolumab 29Carboplatin 29Radiosurgery 27Standard of Care 26Oxaliplatin 26Capecitabine 25Paclitaxel 24Interviews as Topic 24Cisplatin 24Fluorouracil 23Erlotinib Hydrochloride 22Everolimus 19Irinotecan 18Trastuzumab 17Methods 17Exercise 17Docetaxel 17Biopsy 17Cyclophosphamide 16Educational Status 15Sorafenib 14Ipilimumab 14Fluorodeoxyglucose F18 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Aspirin × Tumor-Agnostic × Clear all
NCT01968798 2021-04-05

ACES

Hennepin Healthcare Research Institute

Phase 4 Unknown
14,500 enrolled
Tumor-Agnostic

Neoplasms

NCT04256525 2020-06-30

Prophylactic Anticoagulation for Catheter-related Thrombosis

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 4 Unknown
1,640 enrolled
Tumor-Agnostic

Neoplasms

NCT02323516 2015-12-08

ASPIDIA

Centre Francois Baclesse

Phase 2 Withdrawn
Tumor-Agnostic

Neoplasms

NCT01496521 2011-12-21

CREAT

Beijing Friendship Hospital

Phase 3 Unknown
600 enrolled
Tumor-Agnostic

Carcinoma, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡